This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Taber DJ, Weimert NA, McGillicuddy JW, Mensching KJ, Habib TY, Cattanach LA, Bratton CF, Lin A, Simpsom KN, Chavin KD, Baliga PK.An economic and clinical outcomes analysis comparing anti-lymphocyte antibody induction to IL-2 receptor antibody induction in kidney transplant patients with delayed graft function. American Transplant Congress -- 9th Joint Congress of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST): 384 abstr. 659, 30 May 2009. Available from: URL: http://www.atcmeeting.org
Rights and permissions
About this article
Cite this article
Costs can be cut depending on transplant induction regimen. Pharmacoecon. Outcomes News 581, 4 (2009). https://doi.org/10.2165/00151234-200905810-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905810-00010